Therapeutics: Interleukin-1 receptor accessory protein (IL-1RAP)

Cancer

INDICATION: Acute myelogenous leukemia (AML)

In vitro and mouse studies suggest anti-IL-1RAP antibodies could

Read the full 138 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE